Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Subhash Chandra Yadav | Health Professions | Best Researcher Award

Posted on by Book of Award

Prof. Dr. Subhash Chandra Yadav | Health Professions | Best Researcher Award

All India Institute of Medical Sciences, New Delhi | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits 🎓

Prof. Dr. Subhash Chandra Yadav began his academic journey with an MSc in Biotechnology from Banaras Hindu University (BHU), Varanasi, in 2003. His thirst for knowledge led him to pursue a Ph.D. in Molecular Biology at BHU, which he completed in 2007 under the mentorship of Prof. Jagannadham V. Medicherla. His doctoral research focused on "Milin," a highly stable glycosylated dimeric plant serine protease from Euphorbia milii, examining its structure, function, folding, and crystallographic properties. During his academic development, he also gained international exposure as a research trainee at the Institute of Crystallography, Free University (FU) Berlin, Germany, from September 2005 to April 2006, where he honed his skills in protein structural biology.

Professional Endeavors and Milestones 💼

Dr. Yadav's illustrious career spans prestigious institutions globally:

  • Postdoctoral Fellowships: He worked on molecular biophysics at the Indian Institute of Science (IISc), Bangalore, and at the Graduate School of Medicine, University of Tennessee, USA.
  • Research and Leadership Roles: As a Scientist and In-Charge of Nanobiology and Electron Microscopy Facility at CSIR-IHBT, Palampur, and Fellow at TERI-Deakin Nanobiotechnology Centre, he spearheaded cutting-edge research.
  • Academic Excellence: He has been serving All India Institute of Medical Sciences (AIIMS), New Delhi, since 2015, rising to the role of Additional Professor. He was also a Visiting Professor at Stanford University, USA, in 2019-2020.

Contributions and Research Focus 🔬

Dr. Yadav’s research interests are at the confluence of nanotechnology, molecular biology, and microscopy:

  • Electron Microscopy and Cryo-Electron Tomography: Advancing the understanding of cellular structures at atomic resolution.
  • Nano-enabled Diagnostic Tools: Innovating methods for rapid and accurate disease detection.
  • Targeted Drug Delivery Systems: Developing nanoparticles for precise therapeutics.

His work includes over 6,630 citations, with an h-index of 18, reflecting the impact of his research. His patent portfolio includes innovative detection kits, cancer diagnostics, and nanotechnology-based systems.

Accolades and Recognition 🏆

Dr. Yadav's groundbreaking contributions have earned him numerous accolades:

  • 2024: Fellow of the Electron Microscopy Society of India.
  • 2019: Long-Term Fellowship from the Department of Health Research to work at Stanford University.
  • 2018: Excellence in Microscopy Award by the Electron Microscope Society of India.
  • 2005-2006: Boehringer Ingelheim Fonds Fellowship, Germany.

Impact and Influence 🌍

Dr. Yadav has significantly influenced the fields of nanotechnology and microscopy through his teaching, research, and mentorship. As a member of prestigious societies like the Indian Biophysical Society and a reviewer for leading journals, he has contributed to advancing scientific knowledge. His innovative patents and publications continue to inspire advancements in diagnostics and therapeutics.

Legacy and Future Contributions Highlight 🚀

With a career defined by scientific rigor, international collaboration, and a vision for impactful research, Dr. Yadav stands as a beacon of innovation. His ongoing work in nanotechnology and cryo-electron tomography promises to shape the future of medical diagnostics and targeted therapies, leaving a lasting legacy in science and technology.

 

Publications

📄 Magnetic nanoparticles and quantum dots coupled immuno nano fluorescence assay for visual detection of HPV16-induced cervical cancer cells from cytology/biopsy samples
Authors: Raman, S., Tanwar, P., Meena, J., Bhatla, N., Yadav, S.C.
Journal: Sensing and Bio-Sensing Research
Year: 2024

📄 Genetics of 67 patients of suspected primary ciliary dyskinesia from India
Authors: Jat, K.R., Faruq, M., Jindal, S., Arava, S.K., Kabra, S.K.
Journal: Clinical Genetics
Year: 2024

📄 Quantitative and qualitative analysis of metallic ion release of orthodontic brackets in three different pH conditions - An invitro study
Authors: DA, P., Angel L, S., Chaudhari, P.K., Yadav, S.C., Duggal, R.
Journal: Journal of Oral Biology and Craniofacial Research
Year: 2024

📄 Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis
Authors: Gaur, P., Rajendran, Y., Srivastava, B., Ahuja, V., Srikanth, C.
Journal: eLife
Year: 2024

📄 Visual, rapid, and cost-effective BK virus detection system for renal transplanted patients using gold nanoparticle coupled loop-mediated isothermal amplification (nanoLAMP)
Authors: Kumar, S., Raman, S., Sesham, K., Mridha, A.R., Yadav, S.C.
Journal: Journal of Virological Methods
Year: 2024

 

Filippo Carannante | Medicine and Dentistry | Best Research Award

Posted on by Book of Award

Dr. Filippo Carannante | Medicine and Dentistry | Best Research Award 

UOC Chirurgia Colorettale, Fondazione Policlinico Campus Bio-Medico di Roma | Italy 

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Filippo Carannante's academic journey began at the Bio-Medico Campus University of Rome, where he graduated with a degree in Medicine and Surgery, achieving a perfect score of 110/110 cum laude. He completed a specialized training program in General Surgery Residency at the same institution, culminating in a thesis on the oncological outcomes of rectal cancer patients. He further enhanced his expertise with various fellowships and specialized courses, including a PhD program in Biomedical Sciences and Bioethics focused on osteo-oncological diseases.

💼 Professional Endeavors

Dr. Carannante has held several prestigious positions in the field of colorectal and oncological surgery. Since November 2021, he has been a consultant colorectal surgeon at the Campus Bio-Medico Polyclinic Foundation of Rome. In September 2023, he was appointed a professor of Oncological and Digestive Surgery at the Campus Bio-Medico University of Rome. He is also an active member of the Italian Society of Colorectal Surgery (SICCR) and the Italian Society of Surgical Oncology (SICO), where he serves on the young boards, and is part of the Lower GI Group at the American College of Surgeons (ACS).

🔬 Contributions and Research Focus

Dr. Carannante's research contributions are significant, particularly in the areas of colorectal surgery and minimally invasive surgical techniques. His work includes innovative studies on the outcomes of rectal cancer treatments and the feasibility of minimally invasive colectomy in fragile patients. He has also contributed to advancements in laparoscopic and abdominal wall surgery, and has been involved in multiple research projects at renowned institutions across Europe.

🏆 Accolades and Recognition

Dr. Carannante has received numerous awards for his contributions to surgery and research. Notably, he was awarded the "Ettore Ruggieri" Scholarship by the Italian Society of Surgery (SIC) in 2023 and the "Francesco Mazzeo" Award by the Italian Society of Pathology of the Digestive System (SIPAD) in 2024. Additionally, he received the "Best Oral Presentation" award at a national congress for his study on minimally invasive colectomy.

🌍 Impact and Influence

Dr. Carannante's influence extends beyond his immediate professional environment. He serves on the editorial boards of several prestigious journals, including the International Journal of Colorectal Disease and the World Journal of Surgical Oncology. His h-index of 15 and over 828 citations highlight the impact of his research on the global medical community. He is also a reviewer for numerous scientific publications, ensuring the quality and advancement of research in his field.

🏅 Legacy and Future Contributions

Dr. Carannante's legacy is marked by his dedication to advancing the field of colorectal and oncological surgery through both clinical practice and research. His ongoing roles in various surgical societies and academic institutions position him to continue making significant contributions to the medical field. His commitment to education, research, and clinical excellence ensures that his influence will be felt for years to come, inspiring future generations of surgeons and researchers.

 

Publications 📄

📄Evaluation of Short-Term Effects on Colorectal Surgery Elective Patients after Implementing a Patient Blood Management Program: A Multicenter Retrospective Analysis
Authors: Filippo Carannante, Gabriella Teresa Capolupo, Manuel Barberio, Amedeo Altamura, Valentina Miacci, Martina Zenobia Scopigno, Erika Circhetta, Gianluca Costa, Marco Caricato, Massimo Giuseppe Viola
Journal: [Special Issue: Challenges in Minimally Invasive Colorectal and Abdominal Wall Surgery], Year : 2024

📄Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group)
Authors: Anania, G., Chiozza, M., Campagnaro, A., Zago, M., Zerbinati, A.
Journal: Surgical Endoscopy, Year : 2024

📄Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study
Authors: Rottoli, M., Spinelli, A., Pellino, G., Rausa, E., Celentano, V.
Journal: British Journal of Surgery, Year : 2024

📄Long-term patient-reported outcomes after anti-reflux surgery for gastroesophageal reflux disease and hiatal hernia repair: a single-center experience
Authors: Peltrini, R., Carannante, F., Giovine, G., Capolupo, G.T., Borzomati, D.
Journal: Minerva Surgery, Year : 2023

📄Surgeons’ practice and preferences for the anal fissure treatment: results from an international survey
Authors: Balla, A., Saraceno, F., Shalaby, M., Ziprin, P., Zizzo, M.
Journal: Updates in Surgery, Year : 2023